Takip et
Graeme Prosperi-Porta
Graeme Prosperi-Porta
University of Ottawa Heart Institute
ottawaheart.ca üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Methodological quality of COVID-19 clinical research
RG Jung, P Di Santo, C Clifford, G Prosperi-Porta, S Skanes, A Hung, ...
Nature communications 12 (1), 943, 2021
1762021
Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery
G Prosperi-Porta, S Kedzior, B Muirhead, H Sheardown
Biomacromolecules 17 (4), 1449-1457, 2016
1062016
Aortic stenosis progression: a systematic review and meta-analysis
N Willner, G Prosperi-Porta, L Lau, AY Nam Fu, K Boczar, A Poulin, ...
Cardiovascular Imaging 16 (3), 314-328, 2023
432023
Antimicrobial silver iodate
ME Olson, PL Nadworny, G Prosperi-Porta
US Patent 10,434,210, 2019
252019
Echocardiography-derived stroke volume index is associated with adverse in-hospital outcomes in intermediate-risk acute pulmonary embolism: a retrospective cohort study
G Prosperi-Porta, K Solverson, N Fine, CJ Humphreys, A Ferland, ...
Chest 158 (3), 1132-1142, 2020
212020
Association of age and sex with use of transcatheter aortic valve replacement in France
G Prosperi-Porta, V Nguyen, N Willner, J Dreyfus, H Eltchaninoff, ...
Journal of the American College of Cardiology 82 (20), 1889-1902, 2023
192023
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis
G Prosperi-Porta, P Ronksley, O Kiamanesh, K Solverson, P Motazedian, ...
European Respiratory Review 31 (166), 2022
192022
Ag5IO6: novel antibiofilm activity of a silver compound with application to medical devices
V Incani, A Omar, G Prosperi-Porta, P Nadworny
International journal of antimicrobial agents 45 (6), 586-593, 2015
182015
Rapid prediction of adverse outcomes for acute normotensive pulmonary embolism: derivation of the Calgary Acute Pulmonary Embolism score
K Solverson, C Humphreys, Z Liang, G Prosperi-Porta, JE Andruchow, ...
ERJ Open Research 7 (2), 2021
172021
Significant valvular dysfunction and outcomes in cardiogenic shock: insights from the randomized DOREMI trial
S Parlow, W Weng, P Di Santo, RG Jung, MF Lepage-Ratte, ...
Canadian Journal of Cardiology 38 (8), 1211-1219, 2022
162022
Diagnostic accuracy of point-of-care ultrasound with artificial intelligence-assisted assessment of left ventricular ejection fraction
P Motazedian, JA Marbach, G Prosperi-Porta, S Parlow, P Di Santo, ...
NPJ Digital Medicine 6 (1), 201, 2023
112023
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial
G Prosperi-Porta, P Motazedian, P Di Santo, RG Jung, S Parlow, ...
Journal of Cardiology 80 (4), 358-364, 2022
112022
Multiple thromboembolic events from a left atrial appendage occlusion device
G Prosperi-Porta, G Schnell, J Colbert, A Franko, SB Wilton, VP Kuriachan
Canadian Journal of Cardiology 34 (3), 342. e13-342. e15, 2018
112018
Tunable release of ophthalmic therapeutics from injectable, resorbable, thermoresponsive copolymer scaffolds
G Prosperi‐Porta, B Muirhead, H Sheardown
Journal of Biomedical Materials Research Part B: Applied Biomaterials 105 (1 …, 2017
112017
Ventricular-arterial decoupling is associated with in-hospital adverse events in normotensive pulmonary embolism
O Kiamanesh, G Prosperi-Porta, L Harper, K Solverson, P Boiteau, ...
The International Journal of Cardiovascular Imaging 38 (12), 2655-2665, 2022
102022
Mucoadhesive nanoparticles for drug delivery to the anterior eye
N Mangiacotte, G Prosperi-Porta, L Liu, M Dodd, H Sheardown
Nanomaterials 10 (7), 1400, 2020
102020
Inotrope versus placebo therapy in cardiogenic shock: rationale and study design of the CAPITAL DOREMI2 trial
S Parlow, P Di Santo, LH Sterling, L Goodliffe, P Motazedian, ...
American heart journal 262, 83-89, 2023
92023
Myositis from intramuscular oil injections in a bodybuilder
G Prosperi-Porta, C Oleynick, S Vaughan
CMAJ 192 (18), E480-E480, 2020
72020
Efficacy of milrinone and dobutamine in cardiogenic shock: an updated systematic review and meta-analysis
O Abdel-Razek, P Di Santo, RG Jung, S Parlow, P Motazedian, ...
Critical Care Explorations 5 (9), e0962, 2023
62023
Milrinone vs dobutamine for the management of cardiogenic shock: implications of renal function and injury
P Di Santo, K Dehghan, B Mao, RG Jung, D Fadare, J Paydar, S Parlow, ...
JACC: Advances 2 (5), 100393, 2023
42023
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20